assays demonstrated that miR-30 family members inhibit Smad1 gene expression based on repression its translation. Furthermore, dual-luciferase reporter assays confirmed that Smad1 is a direct target of miR-30 family members. Rescue experiments that overexpression of Smad1 and Runx2 significantly eliminate the inhibitory effect of miR-30 on osteogenic differentiation, provided strong evidence that miR-30 mediate the inhibition of osteogenesis by targeting Smad1 and Runx2. Also, the inhibitory effects of miR-30 family were validated in mouse bone marrow mesenchymal stem cells (MSCs). Therefore, our study uncovered that miR-30 family members are key negative regulators of BMP-2-mediated osteogenic differentiation.
microRNAs (miRNAs) consisting of 18-25 nucleotides belong to the single-stranded small noncoding RNA family (1) (2) (3) (4) (5) (6) . They bind to the 3'UTR of specific target genes and regulate expression of the target genes by promoting the degradation of transcribed mRNAs or by inhibiting their translation (7) . Recent studies indicate that miRNAs are important players during the osteogenic differentiation (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) .
In previous study, we investigated the expression profiles of miRNAs in MC3T3-E1 cells treated with Emdogain ® , a clinical cocktail of enamel matrix proteins that can induce biomineralization and osteogenesis (19) (20) (21) (22) (23) . The data indicated that the expression levels of some miR-30 family members, such as miR-30a, -30b, -30c, and -30d, were significantly down-regulated during the osteoblast differentiation. Studies by others also found that miR-30a and miR-30d are down-regulated during BMP-2 induced osteogenesis of C2C12 mesenchymal cells (15) . Considering that miR-30 family members decreased during osteogenesis induced by different stimuli, it is possible that they may play important roles in the process.
Here we investigated the effects of miR-30 family on osteoblastic differentiation. We found that miR-30a, -30b, -30c, and -30d expression were down-regulated during BMP-2 stimulation. And they were demonstrated inhibiting osteoblast differentiation. Further studies identified Smad1 and Runx2 as common target genes of miR-30 family members. Finally, rescue experiments showed that overexpression of Smad1 and Runx2 significantly eliminate the inhibitory effect of miR-30 on osteogenic differentiation. All these data indicated that miR-30 family members function as negative regulators of osteoblastic differentiation by targeting the master osteogenic transcription factors Smad1 and Runx2. These findings may provide new insights into understanding the regulatory role of miRNAs in the process of osteogenic differentiation.
Experimental procedures
Reagents-Bioactive recombinant human BMP-2 was purchased from Novoprotein Scientific, Inc (Shanghai, China). Anti-Smad1 (#1649-1) was purchased from Epitomics, Inc (Burlingame, CA, USA). Anti-phospho-Smad1/5 (#9516) was purchased from Cell Signaling (Danvers, MA, USA). Anti-Runx2 (S-19) and anti-Smad5 (D-20) were purchased from Santa Cruz biotechnology, Inc (California, USA Dual-Luciferase Reporter assay-To determined the common target region of miR-30 family in Smad1, a segment in the 3'-UTR of the mouse Smad1 cDNA was amplified from genomic DNA using primers 5'-CCG CTC GAG AAG GAT GGA CAA GTC AGA C-3'/5'-ATA GTT TAG CGG CCG CCT GCG AAT AAT GAA CAG AG-3', and cloned between the XhoI and NotI sites of psiCHECK-2 (Promega, Madison, Wisconsin, USA). The template psiCHECK-2-Smad1-3'UTR and the primers 5'-GCA AGA ACC CTT TCA CAA AAC ATT GTG ACA TTC T-3'/5'AGA ATG TCA CAA TGT TTT GTG AAA GGG TTC TTG C-3' (psiCHECK-2-Smad1-mut1) or 5'-GAG CAG TTT TTA TGG ACA AAA CAG TAC AGA CAT AG-3'/5'-CTA TGT CTG TAC TGT TTT GTC CAT AAA AAC TGC TC-3' (psiCHECK-2-Smad1-mut2) were used to generate two different seed region mutant (psiCHECK-2-Smad1-mut -3′UTR) construct by using KOD-Plus (Toyobo Co., Ltd, Biochemical Operations Department, Osaka, Japan). Both of the two target sites mutation construct was cloned by using the template psiCHECK-2-Smad1-mut1 and the primers 5'-GAG CAG TTT TTA TGG ACA AAA CAG TAC AGA CAT AG-3'/5'-CTA TGT CTG TAC TGT TTT GTC CAT AAA AAC TGC TC-3'. MC3T3-E1 cells plated in 24-well flat-bottomed plates were transiently co-transfected with 100 ng of each reporter construct (wild-type and mutant Smad1-3'UTR, and the psiCHECK-2 vector), and the synthetic miR-30 or control miR-NC using Lipofectamine 2000 reagent (Invitrogen). Firefly and Renilla luciferase activities were determined 24 hours after transfection using the Dual-Luciferase Reporter Assay System (Promega). The Renilla values were normalized to Firefly luciferase. 
Construction of Smad1 and Runx2 expression vectors-

Results
Dynamic changes of miR-30 family members during BMP-2-induced osteoblast differentiation in MC3T3-E1 cells-It has been indicated that some
miR-30 family members are down-regulated during osteogenic differentiation (15) . And our previous studies also found that more than one members of miR-30 family significantly decreased in response to osteogenesis-related stimuli (data unpublished), suggesting that miR-30 family may be important for osteogenic differentiation.
To determine whether miR-30 family members are related to osteogenesis, their kinetics were examined following BMP-2 treatment across a 24-h time course. miR-30 family has six members, miR-30a, -30b, -30c, -30d, -30e and miR-384-5p. The expression levels of miR-30a, -30b, -30c, and -30d were down-regulated. They reached their minimum levels at 8-h, and then slightly increased (Fig.1) . However, miR-30e didn't change. And miR-384-5p could not be detected in MC3T3-E1 cells. These data indicated that miR-30a, -30b, -30c, and -30d appeared to be involved in the pre-osteoblast differentiation of MC3T3-E1 cells induced by BMP-2.
Effects of miR-30 family members on osteoblast differentiation in MC3T3-E1 cells-
It is well known that ALP activity increases in a time-dependent manner in MC3T3-E1 cells after treatment with BMP-2 (25, 26) . To determine whether miR-30 could affect osteoblast differentiation, miR-30 family mimics (miR-30a, -30b, -30c, -30d) or inhibitors (as-miR-30a, -30b, -30c, -30d) were transfected into MC3T3-E1 cells respectively, followed by BMP-2 treatment for 7 days. Then the ALP activities in the transfected cells were investigated. As shown in Fig. 2A and 2C , the ALP activities in the miR-30 over-expressing cells were significantly suppressed compared with those in the miR-NC transfected cells. On the contrary, knockdown of miR-30 expression increased the ALP activities ( Fig. 2B and 2D ). We also observed that miR-30 inhibited ALP mRNA levels in a dose-dependent manner ( Fig. 2E and 2F ). These results suggested that miR-30 family members act as negative regulators in osteogenesis induced by BMP-2 stimulation.
Smad1 and Runx2 are common targets of miR-30 family-To identify the target genes of miR-30 in osteogenesis, we searched for candidate genes using the miRNA target prediction databases TargetScan 5.1. Members of the miR-30 family were predicted to target Smad1 and Runx2, which are key downstream mediators of BMP signaling during bone formation (27) (28) (29) . There are two and four predicted target sites in the 3'UTR of Smad1 and Runx2, respectively. And the sequences of these target sites are highly conserved in different vertebrate species (Fig. 3A and Supplemental  Fig. 1 ). Runx2 has been demonstrated to be a direct target of miR-30 family members (30, 31) . However, the function of miR-30 on Smad1 during osteogenic differentiation has not been reported. To test whether Smad1 could be regulated by miR-30, we transfected MC3T3-E1 cells with miR-30 mimics or inhibitors, respectively. The results showed that following transfection, the protein levels of Smad1 decreased when the levels of miR-30a, -30b, -30c, -30d increased. In contrast, the expression of Smad1 increased after knockdown of miR-30a, -30b, -30c or -30d. Of note, Smad1 protein level in the as-miR-30a-d mixture (as-miR-30m) co-transfected cells showed nearly a 5-fold increase compared with the control cells, indicating that miR-30 family members are important negative regulators of Smad1 (Fig. 3B) . Similar changes in Runx2 protein expression were observed (Fig. 3B) . These results provide evidence that miR-30 family negatively regulate Smad1 and Runx2 expression. Furthermore, qRT-PCR assays demonstrated that Smad1 mRNA did not change in miR-30 overexpressing cells (Fig. 3C) , indicating that miR-30 family members regulate Smad1 gene expression based on translational repression rather than mRNA degradation.
To examine whether miR-30 could directly regulate Smad1 expression, MC3T3-E1 cells were transfected with a luciferase reporter construct containing the wild-type Smad1 3'UTR, together with the miR-30a, -30b, -30c, -30d, miR-30a-d mixture, miR-NC, as-miR-30a, -30b, -30c, -30d, as-miR-30a-d mixture or oligo-ctrl, respectively. Clearly, Renilla luciferase activities decreased in miR-30 over-expressing cells, and they increased in miR-30 knock-down cells compared with those in the control cell ( Fig. 4A  and 4B ). Then, one or both of the predicted target sites in Smad1 3'UTR were mutated (Fig.  4C) . As expected, miR-30 significantly inhibited the activities of wild-type reporter gene, whereas mutation of either seed site partially abolished miR-30-mediated repression of reporter gene activities. Furthermore, mutation of both seed sites completely abolished the repression by miR-30 (Fig. 4D) . These data provide strong evidence that miR-30 family members inhibit Smad1 gene expression by directly binding to the two distinct seed sites within its 3'-UTR.
miR-30 family function through Smad1 and Runx2 -To better understand the relationship between miR-30 family members and their targets during osteogenic differentiation, MC3T3-E1 cells stimulated with BMP-2 for 24 hours were evaluated for changes of endogenous
Smad1 and Runx2 protein expression. The increase of Smad1 and Runx2 protein levels was observed 8 hours after stimulation. Then the Smad1 protein slightly decreased (Fig. 5A) . The changes of Smad1 and Runx2 protein expression were found to be negatively correlated with that of miR-30 during BMP-2 stimulation (Fig. 1) . These results suggest that the early down-regulation of miR-30 expression, immediately after BMP-2 treatment, may facilitate releasing their suppression of Smad1 and Runx2 expression.
Upon binding of the BMP ligand to the type I and type II receptor complexes, the activated type I receptor phosphorylates Smad1/5/8, which then assemble into complexes with Smad4 and translocate into the nucleus to regulate the expression of genes related to osteoblast differentiation, such as ALP and OSC (32, 33) . To study whether the BMP-2-Smad1 pathway could be affected by miR-30, MC3T3-E1 cells were transfected with miR-30 (miR-30a, -30b, -30c, or -30d) or ctrl, oligo-Ctrl or as- miR-30 (as-miR-30a, -30b, -30c, or -30d) , and then were treated with BMP-2 for 30 min. Changes in Smad1, Smad5, and phospho-Smad1/5 (p-Smad1/5) protein levels were determined by Western blot analysis. Similar to Smad1, the expression levels of p-Smad1/5 decreased in miR-30 over-expressing cells, while they increased in the miR-30 knock-down cells (Fig. 5B) .
To confirm the speculation that miR-30 family function through Smad1 and Runx2, miR-30a-d mixture, together with wild type Smad1 overexpressing plasmid, 3'UTR-mutant Smad1 overexpressing plasmid, wild type Runx2 overexpressing plasmid or 3'UTR-mutant Runx2 overexpressing plasmid were co-transfected into MC3T3-E1 cells. It demonstrated that transfection with 3'-UTR mutant Smad1 and Runx2 expressing plasmids were able to eliminate the difference in Smad1 and Runx2 protein levels between miR-30 transfected and control cells (Supplemental Fig. 2 ). When stimulated with BMP-2, the overexpression of Smad1 and Runx2 significantly abolished the inhibitory effects of miR-30 on the ALP expression (Fig. 5C ). All these data provide evidence that miR-30 mediate the inhibition of osteogenesis by targeting Smad1 and Runx2. miR-30 inhibit osteogenic differentiation of primary mouse bone marrow MSCs-Finally, we addressed the functional activities of miR-30 family members in primary mouse bone marrow MSCs. miR-30a, -30b, -30c, -30d, and miR-30a-d mixture, miR-NC, as-miR-30a, -30b, -30c, -30d, and as-miR-30a-d mixture or oligo-ctrl were transfected into mouse MSCs, respectively. It demonstrated that during the osteogenic differentiation, the miR-30 family overexpression inhibited the expression levels of ALP, OSC, BSP and OSX, while knockdown of miR-30 family increased their expression levels (Supplemental Fig. 3) . Furthermore, the ALP activities were significantly suppressed or enhanced in the miR-30a-d mixture or as-miR-30a-d mixture transfected cells, which were compatible with the results of Alizarin red staining (Fig. 6) . Both Smad1 and Runx2 were found inhibited by miR-30 in MSCs (Supplemental Fig. 4) . Therefore, these results indicate that miR-30 family members negatively regulate the osteogenic differentiation of mouse bone marrow MSCs.
Discussion
miR-30 family consists of miR-30a, -30b, -30c, -30d, -30e, and -384-5p. The kinetics of miR-30a, -30b, -30c, and -30d in MC3T3-E1 cells stimulated by BMP-2 are similar (Fig. 1) . It suggests that they may play the similar roles in osteoblast differentiation. Here, we provide evidence for the concept that miR-30 family members (miR-30a, -30b, -30c, -30d) regulate osteoblast differentiation and alter the levels of critical molecule of BMP pathways. In contrast, miR-384-5p was undetected. And miR-30e didn't change in response to the BMP-2 stimulation (Fig. 1) . Others also found not all miR-30 family members changed during osteogenic differentiation induced by BMP-2 in C2C12 cells (15) . It is possible that the expression of miR-30 family members are differently regulated.
To investigate the effects of miR-30 family members on BMP-2-induced osteogenic differentiation, we first examined the efficiency and specificity of mimics and inhibitors for miR-30 used in subsequent experiments. Overexpression or knockdown of each member barely not affect other members' expression levels (Supplemental Fig. 5 ). miR-30 family overexpression led to decreased ALP activities while knockdown of them made both mRNA and protein levels of ALP increased compared with the control cells ( Fig. 2A and D) . The same effects were also observed in mouse bone marrow MSCs by overexpressing or inhibiting miR-30 ( Fig. 6 and Supplemental Fig. 3 ). These data suggest that miR-30 family members are the negative regulators of osteoblast differentiation induced by BMP-2 in both pre-osteoblast cell lines and primary cells.
Smad1 is an immediate downstream transducing molecule of the BMP receptor and plays an important role in mediating BMP signaling (34) . Osteoblast-specific Smad1 gene knock-out mice present with impaired postnatal bone formation (35) . So far, several miRNAs have been reported to target Smad1 and regulate its expression in different physiologic conditions. For example, miR-26a regulated osteogenic differentiation of human adipose tissue-derive stem cells by targeting Smad1 transcription factor (36) . miR-199a* was found to adversely regulate early chondrocyte differentiation via directly targeting Smad1 (37) . miR-155 targets the 3'UTR of multiple components of the BMP signaling cascade, including Smad1 in normal and virus-infected cells (38) . Our studies also found new miRNAs regulating Smad1 expression in osteoblast differentiation, indicating that Smad1 could be regulated by different miRNAs under different conditions.
In this study, we found two potential binding sites of miR-30 in the Smad1 3'UTR using bioinformatic analysis and provided direct evidence that Smad1 was the common target of miR-30 family members (Fig. 3 and Fig. 4) .
Mutation of both sites partially eliminate the inhibitory effect of exogenous miR-30 (Fig. 5C ). It should be highlighted that in the miR-NC transfected samples, mutation of either or both sites led to obviously higher Renilla luciferase activities. Considering that mutation of binding sites also abolished the inhibitory function of endogenous miR-30, the result further supported the conclusion that both of these two sites are important for regulation of Smad1 expression.
Besides osteogenesis, it would be interesting to investigate the role of miR-30 in osteoclast differentiation as well, or particularly in chondrocyte differentiation, as Smad1 signaling is also involved in chondrogenesis (37) . Although we have found that miR-30 family members are associated with osteogenic differentiation of mouse bone marrow MSCs ( Fig. 6 and Supplemental Fig. 3) , it remains to be determined whether they are differentially expressed in cartilage, bone, or both. Future in vivo experiments in mouse model are necessary to address miR-30 function in-depth. In addition to BMP pathways, Smad1 is also a mediator of TGF-β pathways in several non-endothelial cell lineages (39) , so it is possible that miR-30 family may be involved in regulating TGF-β signaling pathways.
In conclusion, we demonstrated that the members of miR-30 family in response to BMP-2, act as the negative regulators of early osteoblast differentiation through their suppression of Smad1 and Runx2 transcription factors. This study provides new insights into BMP/Smad signaling regulation in osteoblast differentiation. 
